Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) (Jade)
This study has been completed.
Study NCT00561574 Information provided by Merck Sharp & Dohme Corp.
First Received on November 19, 2007. Last Updated on June 5, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sleep Disorder, Intrinsic
Additional conditions recognized in this trial
Sleep Disorders, Intrinsic
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Nervous System Diseases
Schizophrenia and Disorders with Psychotic Features
Signs and Symptoms
Interventions listed in this trial
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers